Furthermore, clinical imaging studies also indicate that TSPO significantly increases in neurodegenerative and neurological diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) (Ouchi et al., 2005; Gerhard et al., 2006; Edison et al., 2008; Yasuno et al., 2008). This evidence concerns the gene TSPO and Parkinson disease.